Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of 305.46 billion. The enterprise value is 316.57 billion.
| Market Cap | 305.46B |
| Enterprise Value | 316.57B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Aug 15, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.71% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.18B |
Valuation Ratios
The trailing PE ratio is 21.79.
| PE Ratio | 21.79 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 67.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 30.90.
| EV / Earnings | 22.58 |
| EV / Sales | 7.51 |
| EV / EBITDA | 14.72 |
| EV / EBIT | 15.59 |
| EV / FCF | 30.90 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.74 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | 1.39 |
| Interest Coverage | 85.29 |
Financial Efficiency
Return on equity (ROE) is 80.78% and return on invested capital (ROIC) is 46.03%.
| Return on Equity (ROE) | 80.78% |
| Return on Assets (ROA) | 22.41% |
| Return on Invested Capital (ROIC) | 46.03% |
| Return on Capital Employed (ROCE) | 56.34% |
| Revenue Per Employee | 524,749 |
| Profits Per Employee | 182,482 |
| Employee Count | 77,349 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.33% in the last 52 weeks. The beta is 0.17, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -46.33% |
| 50-Day Moving Average | 82.12 |
| 200-Day Moving Average | 110.60 |
| Relative Strength Index (RSI) | 28.80 |
| Average Volume (20 Days) | 107,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of 40.31 billion and earned 14.02 billion in profits. Earnings per share was 3.14.
| Revenue | 40.31B |
| Gross Profit | 34.27B |
| Operating Income | 19.42B |
| Pretax Income | 17.66B |
| Net Income | 14.02B |
| EBITDA | 20.36B |
| EBIT | 19.42B |
| Earnings Per Share (EPS) | 3.14 |
Balance Sheet
The company has 3.65 billion in cash and 14.27 billion in debt, giving a net cash position of -10.62 billion.
| Cash & Cash Equivalents | 3.65B |
| Total Debt | 14.27B |
| Net Cash | -10.62B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 19.92B |
| Book Value Per Share | 4.49 |
| Working Capital | -7.86B |
Cash Flow
In the last 12 months, operating cash flow was 16.79 billion and capital expenditures -6.55 billion, giving a free cash flow of 10.25 billion.
| Operating Cash Flow | 16.79B |
| Capital Expenditures | -6.55B |
| Free Cash Flow | 10.25B |
| FCF Per Share | n/a |
Margins
Gross margin is 85.00%, with operating and profit margins of 48.17% and 34.78%.
| Gross Margin | 85.00% |
| Operating Margin | 48.17% |
| Pretax Margin | 43.80% |
| Profit Margin | 34.78% |
| EBITDA Margin | 50.51% |
| EBIT Margin | 48.17% |
| FCF Margin | 25.41% |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | 0.52 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 43.71% |
| Buyback Yield | 0.71% |
| Shareholder Yield | 1.45% |
| Earnings Yield | 4.59% |
| FCF Yield | 3.35% |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 8.94.
| Altman Z-Score | 8.94 |
| Piotroski F-Score | n/a |